LivingGLP1
Study S001607

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

ClinicalTrials.gov record

Registration

Registration
NCT07428746
Acronym
GLOW
Study type
INTERVENTIONAL
Phase
PHASE3
Masking
NONE
Status
RECRUITING
Enrollment
20
Start
2026-05-07
Primary completion
2028-11
Lead sponsor
Emory University
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:Semaglutide
Results posted
FALSE
Individual participant data sharing
YES
Secondary identifiers
NIH:K12AR084234

Registered primary outcomes

  • Change in handgrip strength [Baseline, week4, week 8, week12, week 26.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.